author

 
 

Meta

Kanoko Matsuyama
Japan Times
BUSINESS / Companies
Mar 28, 2022
Activist fund executives on board bolstered Olympus, CEO says
Olympus's shares have more than doubled since ValueAct, a U.S. hedge fund, persuaded Olympus to accept its director nominations in 2019.
Japan Times
WORLD / Science & Health
Mar 25, 2022
Microplastics found in blood for the first time, study says
Scientists found 17 out of the 22 healthy people they took samples from had quantifiable amounts of plastic particles in their blood.
Japan Times
BUSINESS / Companies
Mar 9, 2022
Uniqlo pressured to halt Russia sales after CEO vows to stay
Comments defending the decision by CEO Tadashi Yanai have drawn criticism, with some social media users pushing the hashtag #BoycottUniqlo.
Japan Times
BUSINESS / Companies
Mar 7, 2022
Uniqlo owner pledges to stay in Russia as wave of companies exit
Fast Retailing Co., Asia's largest retailer and parent of Uniqlo, will continue to operate in Russia.
JAPAN
Mar 6, 2022
Shionogi says its COVID-19 shot is effective and safe
The positive data could mean Japan, which is racing to complete a booster drive in hopes of curbing future outbreaks, will soon have an indigenous jab.
Japan Times
BUSINESS / Companies
Feb 25, 2022
Japan Tobacco halts Ukraine plant as fighting intensifies
The safety of all 900 workers at the facility has been confirmed and the company is monitoring developments closely, a spokesman wrote in an email Friday.
JAPAN
Jan 26, 2022
Japan set to miss booster target as omicron muddles rollout plan
About 2.6 million people had received their third dose as of Tuesday, about 18% of the target for January, according to government figures.
Japan Times
BUSINESS
Dec 27, 2021
Tardy COVID-19 vaccine makers under fire for trials in developing nations
Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
JAPAN
Dec 8, 2021
COVID patients in Japan recovering in robot-staffed hotels
Some COVID-19 patients get a hotel booking — and can enroll in clinical trials during their stay — with their positive test results.
Japan Times
WORLD / FOCUS
Dec 4, 2021
We have to live with COVID. Here’s how we get our lives back.
Two years into the pandemic, the emergence of yet another COVID-19 variant means the world will need to find long-term strategies to coexist with delta, omicron and the strains to come.
BUSINESS / Companies
Nov 25, 2021
SoftBank’s Masayoshi Son bets on narcolepsy drug for sleep-deprived Japan
The proportion of people sleeping less than the recommended eight hours is rising globally, and costs Japan as much as $138 billion in economic losses each year, according to Rand Corp.
BUSINESS / Companies
Nov 17, 2021
The cult of Balmuda can now make phone calls
Balmuda, best known for its stylish but expensive toaster, is hoping to bring its know-how to the ultra-competitive smartphone market.
JAPAN
Nov 17, 2021
Japan leads the G7 in COVID shots without a mandate in sight
The country this week pushed ahead of Canada, which previously had the highest rate among the G7 major advanced economies.
Japan Times
JAPAN / Science & Health
Jun 16, 2019
Drug devised to replace chemotherapy may reshape cancer care
A class of drugs is emerging that can attack cancer cells in the body without damaging surrounding healthy ones. They have the potential to replace chemotherapy and its disruptive side effects, reshaping the future of cancer care.
Japan Times
JAPAN / Science & Health
May 29, 2019
Blood test can predict dementia, but Japanese developers urge caution: There's still no cure
Nobel Prize winner Koichi Tanaka says the predictive blood test for Alzheimer's disease he and colleagues spent almost a decade developing is a double-edged sword.
Japan Times
BUSINESS / Companies
Sep 29, 2017
Opioids demand rises in Japan as seniors use drugs to ease pain and improve quality of life
Selling painkillers in Japan used to be like pulling teeth. That was until baby boomers discovered how analgesics could take the sting from arthritis, diabetic nerve damage and the ravages of cancer.
Japan Times
JAPAN
Jul 12, 2017
Pill-popping is a business worth watching for Japan's drugmakers
To eke out growth in one of the developed world's most sluggish pharmaceutical markets, Japanese drugmakers are turning to the pill-popping behavior of their customers.
Japan Times
BUSINESS
Jun 28, 2017
Japan's corporate chiefs face more scrutiny over cushy retirement roles
For decades, boards allowed former executives to linger on as highly paid advisers, without offering shareholders much detail about their roles. Now, there are signs that cushy retirement gigs may no longer be a sure thing.
Japan Times
BUSINESS
Mar 7, 2017
Japan pushes for tighter control on drug pricing, crimping big pharma profits
President Donald Trump has pledged to reverse what he describes as "astronomical" drug prices in the United States. Thousands of kilometers away, Japan, long a profit sanctuary for multinational pharmaceutical companies, is taking a similar tack.
BUSINESS / Companies / FOCUS
Jun 16, 2015
Nobel laureate Yamanaka allies with Takeda in hunt for blockbuster drugs
When Christophe Weber went after his first deal as head of Takeda Pharmaceutical Co., he veered off the well-worn path to the U.S. and Europe and went to Japan's Kyoto University instead.

Longform

Juzo Itami’s “Tampopo” was released Nov. 23, 1985, and though it wasn’t a hit at the time, it has gained a cult following in the years since.
Eat, slurp, love: 'Tampopo' turns 40